The Quest for a Cure Matt Sharp Project Inform/ATAC Tim Horn aidsmeds.com/ATAC.
-
Upload
salvador-raisbeck -
Category
Documents
-
view
239 -
download
17
Transcript of The Quest for a Cure Matt Sharp Project Inform/ATAC Tim Horn aidsmeds.com/ATAC.
The Quest for a The Quest for a CureCure
Matt Sharp Project Inform/ATACMatt Sharp Project Inform/ATAC
Tim Horn aidsmeds.com/ATACTim Horn aidsmeds.com/ATAC
OverviewOverview
Treatment vs. CureTreatment vs. Cure Sterilizing CureSterilizing Cure Functional CureFunctional Cure Preventive VaccinesPreventive Vaccines Treatment as PreventionTreatment as Prevention FundingFunding AdvocacyAdvocacy
22
Treatment vs. CureTreatment vs. Cure
33
44
Why A Cure?Why A Cure?
Chronic and manageable disease?Chronic and manageable disease? HIV drugs, though essential for HIV drugs, though essential for
life in the absence of a cure, take life in the absence of a cure, take a potentially lethal toll on the a potentially lethal toll on the bodies of people with HIV, bodies of people with HIV, precipitating problems ranging precipitating problems ranging from liver cancer to heart attacks from liver cancer to heart attacks
55
More and more people will be More and more people will be taking antiretroviral medications taking antiretroviral medications as treatment guidelines shift and as treatment guidelines shift and treatment-for-prevention treatment-for-prevention programs begin rolling outprograms begin rolling out
Treatment fatigue will become a Treatment fatigue will become a growing concern as well as growing concern as well as cumulative toxicities cumulative toxicities
66
Antiretroviral drugs work well for Antiretroviral drugs work well for most people but… most people but… – Some have discordant or inadequate Some have discordant or inadequate
responses for a variety of known and responses for a variety of known and unknown reasonsunknown reasons
– There are some people who have There are some people who have run out of treatment options despite run out of treatment options despite the number of approved medications the number of approved medications
77
Antiretrovirals are only available Antiretrovirals are only available to 40% of people who need them to 40% of people who need them around the worldaround the world
Providing antiretroviral therapy Providing antiretroviral therapy for every person with HIV/AIDS, for every person with HIV/AIDS, for the rest of their lives, is for the rest of their lives, is financially and logistically financially and logistically problematicproblematic
88
The ultimate goal for research on The ultimate goal for research on any disease is a cure but… any disease is a cure but… – HIV cure research continues to face HIV cure research continues to face
many challenges and complexitiesmany challenges and complexities
99
A cure would save federal dollarsA cure would save federal dollars– The US currently spends $11 billion The US currently spends $11 billion
annually on caring for people with AIDS annually on caring for people with AIDS in the US, and in 2008 spent $6 billion on in the US, and in 2008 spent $6 billion on its successful US global AIDS program its successful US global AIDS program
Would also allow some of the one Would also allow some of the one million people living with HIV in the million people living with HIV in the US to return to work and paying taxesUS to return to work and paying taxes
1010
Different Possible Different Possible “Cures”“Cures”
Sterilizing cure: eliminating all HIV Sterilizing cure: eliminating all HIV from the bodyfrom the body
Functional cure: permanent viral Functional cure: permanent viral suppression without therapysuppression without therapy
Preventive vaccines Preventive vaccines Treatment as prevention: universal, Treatment as prevention: universal,
widespread use of treatment to widespread use of treatment to radically reduce risk of HIV radically reduce risk of HIV transmission transmission
Sterilizing CureSterilizing Cure
1111
1212
The HopeThe Hope
1995: David Ho and others suggest HIV 1995: David Ho and others suggest HIV eradication with early use of drug eradication with early use of drug combinations, much like approach used combinations, much like approach used to cure diseases like TB and leukemiato cure diseases like TB and leukemia One and a half to three years of treatment One and a half to three years of treatment
necessary to kill off two HIV compartments:necessary to kill off two HIV compartments:– Free HIV and actively infected CD4sFree HIV and actively infected CD4s– chronically infected cells (macrophages and chronically infected cells (macrophages and
dendritic cells)dendritic cells)
The RealityThe Reality
1997: Three teams discover third 1997: Three teams discover third compartmentcompartment– Resting, latently infected CD4 Resting, latently infected CD4
memory T-cells potentially lasting a memory T-cells potentially lasting a lifetime lifetime
1313
Ongoing viral replicationOngoing viral replication– Intensifying treatment further reduces VLIntensifying treatment further reduces VL– Chronic inflammationChronic inflammation
What’s causing this?What’s causing this?– Incomplete viral suppression?Incomplete viral suppression?– Intermittent production by stable cells?Intermittent production by stable cells?– Anatomical reservoirs (brain, gut, etc.)Anatomical reservoirs (brain, gut, etc.)
1414
Treatment IntensificationTreatment Intensification
Older ApproachesOlder Approaches Ziagen (abacavir)Ziagen (abacavir) Protease inhibitorProtease inhibitor NNRTINNRTI
Newer ApproachesNewer Approaches MaravirocMaraviroc SelzentrySelzentry
1515
Purging the ReservoirPurging the Reservoir
Older ApproachesOlder Approaches IL-2IL-2 IL-2 and interferon-IL-2 and interferon- OKT3 and IL-2OKT3 and IL-2
Newer ApproachesNewer Approaches IL-7IL-7 HDAC inhibitionHDAC inhibition
– Valproic acidValproic acid ProstratinProstratin HMBAHMBA
1616
1717
D. D. Richman et al., Science 323, 1304 -1307 (2009)
Therapeutic VaccinesTherapeutic Vaccines
Activate transcription of proviral DNA Activate transcription of proviral DNA in the presence of ARV treatmentin the presence of ARV treatment
1818
1919
Gene TherapyGene Therapy
Berlin bone marrow transplant caseBerlin bone marrow transplant case Anti-HIV ribozymesAnti-HIV ribozymes AntisenseAntisense siRNAsiRNA Zinc-finger nucleasesZinc-finger nucleases TRIM5TRIM5 Note:Note: Myleoablative conditioning Myleoablative conditioning
likely requiredlikely required
2020
Is HIV eradication practical? Is HIV eradication practical?
With advances in HIV therapy, is With advances in HIV therapy, is striving for HIV eradication in striving for HIV eradication in more than a few specific cases more than a few specific cases worth the drastic interventions worth the drastic interventions likely to be required to likely to be required to accomplish this? accomplish this?
Are there simpler approaches?Are there simpler approaches?
Functional CureFunctional Cure
2121
2222
Learning from LTNPsLearning from LTNPs
Lessons from long-term Lessons from long-term
nonprogressors and elite controllersnonprogressors and elite controllers– Elite controllers: <1% of PLWHIVElite controllers: <1% of PLWHIV– 50% have strong HIV-specific CD8 cells50% have strong HIV-specific CD8 cells– Other possibilities: NK cells, low CCR5 Other possibilities: NK cells, low CCR5
expression, skewed HLA-C expression, expression, skewed HLA-C expression, low immunoregulatory responselow immunoregulatory response
2323
Early HIV TreatmentEarly HIV Treatment
ARV therapy started during acute ARV therapy started during acute and early HIV infectionand early HIV infection– Can it protect immune function?Can it protect immune function?– Does it result in lower viral load “set Does it result in lower viral load “set
point?”point?”
2424
Therapeutic VaccinesTherapeutic Vaccines
Training the immune system to Training the immune system to better respond to HIV in the better respond to HIV in the absence of ARV treatmentabsence of ARV treatment– An effective preventive vaccine An effective preventive vaccine
could potentially work as a could potentially work as a therapeutic vaccine, and vice versatherapeutic vaccine, and vice versa
Older ApproachesOlder Approaches Whole inactive virus Whole inactive virus
– RemuneRemune Virus-derived gp160Virus-derived gp160 Cell-derived gp160Cell-derived gp160 Canarypox-basedCanarypox-based
– ALVAC 1452ALVAC 1452
Newer ApproachesNewer Approaches Prime-boost (GeoVax)Prime-boost (GeoVax)
– HIV DNA primerHIV DNA primer– MVA (smallpox) boosterMVA (smallpox) booster
Vacc-4x (Bionor Vacc-4x (Bionor Immuno)Immuno)
2525
2626
STIsSTIs
Encouraging initial resultsEncouraging initial results– Berlin PatientBerlin Patient– Small studiesSmall studies
Discouraging follow-up resultsDiscouraging follow-up results– Danger in MDR HIVDanger in MDR HIV– No proven benefitNo proven benefit– SMART studySMART study
Future of STIsFuture of STIs– In combination with immune-based In combination with immune-based
therapies?therapies?– Will these be allowed by FDA?Will these be allowed by FDA?
2727
Preventive VaccinesPreventive Vaccines
2828
2929
The Big PictureThe Big Picture
By inoculating populations HIV would be By inoculating populations HIV would be stoppedstopped
Humoral vs cellular responsesHumoral vs cellular responses Several vaccine candidates have failedSeveral vaccine candidates have failed STEP Merck trial interrupted and STEP Merck trial interrupted and
discontinueddiscontinued RV 144 adenoviral candidate showed 31% RV 144 adenoviral candidate showed 31%
efficacy-trials are ongoingefficacy-trials are ongoing Huge, expensive trials with large cohorts Huge, expensive trials with large cohorts
and complicated scienceand complicated science
Treatment as PreventionTreatment as Prevention
3030
3131
Can universal testing and Can universal testing and treatment snuff out HIV? treatment snuff out HIV?
TLC+ frameworkTLC+ framework
FundingFunding
3232
3333
National Institutes for Health is National Institutes for Health is the largest funder of AIDS the largest funder of AIDS research in the world yet is research in the world yet is underfundedunderfunded
3434
Budget of the NIH has essentially Budget of the NIH has essentially been flat funded since 2003, and been flat funded since 2003, and in constant dollars lost 13.4% of in constant dollars lost 13.4% of its annual spending power by its annual spending power by 2009 due to biomedical inflation 2009 due to biomedical inflation
3535
President Obama’s 2011 proposed President Obama’s 2011 proposed budget would add only 3% to the budget would add only 3% to the overall NIH budget, a continued overall NIH budget, a continued decline in spending power decline in spending power
Due to the current economic crisis, Due to the current economic crisis, President Obama dedicated $10 billion President Obama dedicated $10 billion in Stimulus Package funds to NIH in Stimulus Package funds to NIH research, and about 1/10 of this was research, and about 1/10 of this was designated to NIAID (National Institute designated to NIAID (National Institute of Allergy and Infectious Diseases).of Allergy and Infectious Diseases).
NIAID announced that a portion of NIAID announced that a portion of these funds would be used for basic these funds would be used for basic research into viral persistence—HIV research into viral persistence—HIV eradicationeradication
Fauci has put cure research as one of Fauci has put cure research as one of the top of the NIAID research agendathe top of the NIAID research agenda
3636
AdvocacyAdvocacy
3737
3838
Cure Mobilization Cure Mobilization – educationeducation– misinformationmisinformation– complex informationcomplex information– newnew
Bogus curesBogus cures More research dollarsMore research dollars
3939
IBT Strategy GroupIBT Strategy Group Michael Palm Basic Science, Michael Palm Basic Science,
Vaccines & Prevention Project Vaccines & Prevention Project Weblog Weblog
Project InformProject Inform
www.projectinform.orgwww.projectinform.org HIV Policy Project HIV Policy Project
www.aidspolicyproject.orgwww.aidspolicyproject.org